Many possible pulmonary complications
each containing 20 patients. The groups consisted of patients with chronic renal failure before dialysis (group 1); patients receiving continuous ambulatory peritoneal dialysis, never having received a transplant (group 2); patients receiving haemodialysis, never having received a transplant (group 3); and patients after their first successful cadaveric renal transplant (group 4). All were attending the same regional dialysis and transplant unit. None was known to have clinically important lung or chest wall disease. Flow-volume loops were recorded before and after 400 jg of salbutamol, and plethysmographic lung volumes and airway conductance and single breath carbon monoxide transfer factor were measured. Only nine of 80 patients had normal lung function. The reductions in spirometric values were minor. Whole lung carbon monoxide transfer factor was reduced in all groups (mean % predicted with 95% confidence intervals: group 1 81-7% (74-89%); group 2 69-7% (62-77%); group 3 87-5% (80-96%); group 4 82-5% (78-87%)). The values were significantly lower in those having continuous ambulatory peritoneal dialysis (group 2). Residual volume was reduced significantly in the group who had undergone renal transplantation (85-7%, 77-94%). There was no correlation between these changes and smoking habit, age, duration or severity of renal failure, duration of treatment, or biochemical derangement. It is concluded that abnormal lung function is common in renal disease. The main change is a reduction in carbon monoxide transfer that persists after transplantation. The Results There were differences in age, haemoglobin, calcium, albumin, and alkaline phosphatase between the four groups, as expected (p < 0-01; table 1). Haemoglobin, albumin, and calcium concentrations were highest and alkaline phosphatase activity lowest in the renal transplant group, confirming that biochemical control was improved after cadaveric renal transplantation. Serum albumin concentration was lowest in the group having continuous ambulatory peritoneal dialysis (F = 16-3, p < 0-001).
The mean (95% CI) lung function measurements for each group are shown in table 2 and numbers with an abnormal measurement in table 3. Mean sGaw was within the normal range in all groups.
In group 1 (patients with renal failure not requiring dialysis) spirometric values were essentially within the normal range. There was (2) 10 (4) (2) 4 (3) 1 (-) TLCO or Kco only abnormal 5 (2) 4 (3) 2 (1) 5 (-) *Outside normal range (above 1 3 sa'kPa-').
tSee under "Analysis" for definitions.
For abbreviations see under "Study design."
planted patients with normal renal function (serum creatinine < 120 tmol/l, n = 11) were compared with those for patients with renal impairment (n = 9) the latter showed greater reductions in FEV, (mean (SE) 101 (2 8) v 88 (6 2); p < 0 05) and FVC (104 (4-3) v 89 (5-5); p < 0 05). Other measurements were similar. A reversible component of airway obstruction was diagnosed if either or both the FEV, and FVC rose by more than 10% after salbutamol. Four patients (5%) met these criteria, two in group 2, one in group 1, and one in group 3.
There were no significant differences between groups for spirometric values, TLC, sGaw, VA, or Kco (analysis of variance). In group 4 (with renal transplants) RV was lower than in the other three groups (F = 5 05, p < 0-01). In group 2 (continuous ambulatory peritoneal dialysis), TLCO was lower than in the other three groups (F = 5 10, p < 0 01). There was no difference between non-smokers, current smokers, and ex-smokers for any measurement, whether all 80 patients were considered or each group separately. There was also no correlation in any group between the reduction in TLCO and serum creatinine concentration or its reciprocal, duration of renal failure or its treatment, albumin or calcium concentration, or alkaline phosphatase activity apart from a weak inverse correlation between TLCO and serum albumin in the group having haemodialysis (r = -0 57, p < 0-01). There was no significant correlation between RV and any of these measuremerLts in group 4.
Discussion
We studied 80 patients with kidney disease, all selected for the absence of overt lung disease. This is the first report to compare groups of patients undergoing different forms of treatment in the same renal unit. Our four study groups were not matched, however, and the study was cross sectional, so comparisons between groups must be cautious. Although the patients were selected at random from those attending the renal unit, there was a substantial predominance of men (60 of 80 studied). This may in part reflect different incidences ofcertain renal diseases in men.20 Our main finding was a reduction in carbon monoxide transfer factor with nearly normal spirometric values in all groups, including those with successful renal transplants. Only nine patients had completely normal lung function. We were not able to correlate lung function abnormalities with smoking habit, age, duration or severity of renal failure, or other biochemical derangement.
The most common pathological condition of the lungs in chronic renal failure is pulmonary oedema, usually due to a combination of fluid overload and abnormal permeability of the pulmonary microcirculation."5 Although our patients were free from overt oedema, minor degrees of fluid retention are virtually impossible to detect clinically, and are the likeliest cause of the reduction in carbon monoxide transfer factor in our patients with renal failure and dialysis. Similar findings have been reported by others for patients with chronic renal failure2" or undergoing haemodialysis. [22] [23] [24] We found no acute change in lung function after instilling 2-2 litres of dialysis fluid into the abdomen.'5 Although the group having continuous ambulatory peritoneal dialysis as a whole had a lower carbon monoxide transfer factor than those having haemodialysis, the difference is unlikely to be of major clinical importance except in those with severe pre-existing pulmonary disease. It is also arguable whether haemodialysis would be tolerated by these patients as TLCO may fall further before haemodialysis owing to increased fluid overload and as there may be an acute deterioration in lung function during the dialysis period.2 13 The lack of correlation with duration of renal failure or extent of biochemical impairment is not surprising. Patients We conclude that abnormalities of lung function are very common in renal failure, the major finding being a reduction in carbon monoxide transfer factor. Although haemodialysis may induce acute changes in lung function,'2 13 there seems to be no additional effect on lung function. Continuous ambulatory peritoneal dialysis was associated with a slightly greater reduction in carbon monoxide transfer factor than was found in predialysis and haemodialysis patients. After transplantation the changes were still present, and residual volume was reduced. The pathological basis of these changes cannot be determined from this study. Survival of patients on dialysis and after transplantation is increasing, and non-renal abnormalities are therefore likely to be of increasing importance. Further studies are needed to determine the cause of lung function abnormalities in otherwise apparently healthy patients with kidney disease.
